DPP4 and diabetes mellitus: Regarding oral pharmacological therapy for DM, it has been reported that dipeptidyl peptidase-4 inhibitors (DPP4-I) use may have a beneficial effect on the prevention of loss of muscle mass and its function compared with sulfonylureas [35].